Case 5 Case 5 was a 39-year-old Black female with a 24-year history of T2D using insulin degludec U200 100 units subcutaneously daily, insulin lispro 56 units subcutaneously before breakfast/lunch and 50 units before dinner, metformin 1000 mg by mouth twice daily, pioglitazone 30 mg by mouth once daily, and empagliflozin 25 mg by mouth once daily with a resulting A1C of 7.1%
Monitoring plans should be agreed upon, including the frequency of follow-up appointments, which parameters will be monitored, and when treatment review will occur
Unlike many existing GLP-1 receptor agonists, orforglipron can be taken any time of day without food or water restrictions, offering greater convenience for patients
Evet, Tip-2 diyabet ilac olduu iin inslin direncini krmada ok etkilidir
Contraindications of Semaglutide: What You Should Know Like any medication, semaglutide is not a suitable treatment option for all patients
This class can increase glucose-dependent insulin release, reduce glucagon when glucose is high, slow stomach emptying, and support fullness after eating